TABLE 3.
Variable | Total, n (%) | Delirium, n (%) | No delirium, n (%) | P-value |
Inflammatory markers | ||||
Interleukin-6, pg/mL, Mdn (IQR) | 208.7 (346.7) | 247.2 (383.3) | 178.0 (274.1) | 0.009 |
Interleukin-8, pg/mL, Mdn (IQR) | 89.0 (105.0) | 101.0 (108.3) | 74.0 (97.0) | 0.029 |
Interleukin-10, pg/mL, Mdn (IQR) | 9.9 (10.6) | 10.0 (10.8) | 9.6 (10.1) | 0.668 |
Tumor necrosis factor-α, pg/mL, Mdn (IQR) | 11.3 (6.9) | 12.3 (6.2) | 8.9 (5.6) | <0.001 |
Neutrophil count, × 10^9/L, mean (SD) | 11.74 (4.99) | 12.01 (5.27) | 11.27 (4.45) | 0.143 |
Lymphocyte count, × 10^9/L, mean (SD) | 1.16 (0.43) | 1.18 (0.43) | 1.12 (0.43) | 0.143 |
NLR, Mdn (IQR) | 10.17 (5.60) | 10.23 (5.64) | 10.00 (5.39) | 0.698 |
hsCRP, mg/dL, Mdn (IQR) | 121.8 (152.06) | 140.76 (163.68) | 113.95 (113.14) | 0.094 |
PCT, ng/L, mean (SD) | 10.64 (29.07) | 10.72 (18.26) | 10.50 (42.00) | 0.943 |
Immune parameters, g/L, mean (SD) | ||||
Immunoglobulin A | 1.91 (0.77) | 1.90 (0.76) | 1.92 (0.78) | 0.751 |
Immunoglobulin G | 8.52 (3.02) | 8.33 (2.92) | 8.84 (3.20) | 0.122 |
Immunoglobulin M | 0.72 (0.45) | 0.71 (0.44) | 0.74 (0.47) | 0.602 |
Complement 3 | 0.773 (0.217) | 0.760 (0.234) | 0.796 (0.181) | 0.097 |
Complement 4 | 0.157 (0.056) | 0.155 (0.059) | 0.160 (0.052) | 0.361 |
Lymphocyte subsets, Mdn (IQR) | ||||
Natural killer cell count, cells/μL | 92 (89) | 94 (84) | 86 (95) | 0.211 |
CD19 + B cell count, cells/μL | 129 (142) | 145.5 (160) | 105 (111) | 0.004 |
CD3 + T cell count, cells/μl | 827 (328) | 844.5 (281) | 809 (463) | 0.058 |
CD4 + T cell count, cells/μl | 528 (301) | 566 (182) | 339 (253) | <0.001 |
CD8 + T cell count, cells/μl | 251 (147) | 251.5 (134) | 244 (207) | 0.690 |
CD4/CD8 ratio | 1.93 (1.16) | 2.31 (1.00) | 1.28 (0.83) | <0.001 |
Statistically significant (P < 0.05).
IQR, interquartile range; hsCRP, hypersensitive C-reactive protein; PCT, procalcitonin; NLR, neutrophil to lymphocyte ratio; SD, standard deviation.